# Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With Avastin

> **NCT00635050** · PHASE2 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 32 (actual)

## Conditions studied

- Invasive Breast Cancer

## Interventions

- **DRUG:** Doxil, Paclitaxel, Cyclophosphamide, Avastin

## Key facts

- **NCT ID:** NCT00635050
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2014-12
- **Final completion:** 2015-06
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2016-07-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00635050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00635050, "Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With Avastin". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00635050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*